September 15, 2020 – Announcements
Next month marks the inauguration of Dana Farber / Harvard Cancer Center Neuro-Oncology Grand Rounds, a monthly, multidisciplinary, HMS CME conference open to all DF/HCC institutions (BWH, BIDMC, BCH, DFCI, HSPH, HMS,...
September 02, 2020 – ODQ
Both a quick overview and in-depth step-by-step training and guidance are now available!
August 27, 2020 – Cancer Disparities
Thursday, August 6th capped off a 3-day zoomathon of final presentations from a field of 54 CURE and U54 Partnership students that worked with labs across DF/HCC member institutions this summer. Although Karen Burns...
August 18, 2020
Last week DF/HCC officially awarded its first “Grand Challenge” award to Beverly Moy, MD, MPH (MGH) for her project entitled, “Boosting Clinical Trial Accrual Among Underserved Cancer Patients through Partnerships”
August 18, 2020 – Announcements
The Harvard Chan Bioinformatics Core is excited to expand our bioinformatics training program as part of a new collaboration with the Dana-Farber / Harvard Cancer Center (DF/HCC).
August 06, 2020 – PRMS
On Friday, August 7th, iRIS will undergo a few minor updates. Please review the summary of changes below.
August 05, 2020 – Announcements
New to DF/HCC? Need to know where to start? Submitting a new research project for the first time? Visit this new page for guidance!
August 05, 2020 – Announcements
After a comprehensive search, we are excited to share that Sarah Kiskaddon, J.D. has accepted the role of Director of the Office of Human Research Studies, which includes oversight of the DFCI Institutional Review Board...
August 04, 2020 – Funding
The Kidney Cancer SPORE seeks applications for funding of research on kidney cancer. Applications should be sent no later than noon on 08/24/2020.
July 31, 2020 – COVID-19
The policy exceptions announced on March 23, 2020 have been extended until at least December 31, 2020. An updated note to file has been posted.
The DF/HCC Connect:Science seminar series offers remote participation through Zoom to pull our community of faculty, trainees, and lab staff together during this difficult time and it promotes engagement during these next several weeks.
We’re happy to announce the DF/HCC’s new Center for Cancer Equity and Engagement. Learn how the CCEE is working to bring DF/HCC research and communities together to eliminate cancer disparities in Massachusetts.
This is a collaboration between Dana-Farber/Harvard Cancer Center and the David H. Koch Institute for Integrative Cancer Research, designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.
